BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 37551016)

  • 1. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
    Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
    J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual Screening of
    Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential drug molecules against fibroblast growth factor receptor 3 (FGFR3) by multi-stage computational-biophysics correlate.
    Ahmad S; Almanaa TN; Khan S; Aljahdali SM; Waheed Y; Aljasir MA; Al-Megrin WAI; Aziz A; Ateeq M; Amin F; Khattak SU; Sanami S
    J Biomol Struct Dyn; 2023 Dec; ():1-9. PubMed ID: 38064307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and dynamics of novel scaffolds against
    Alhassan HH; Alruwaili YS; Alzarea SI; Alruwaili M; Alsaidan OA; Alzarea AI; Manni E; Tahir Ul Qamar M
    J Biomol Struct Dyn; 2023 Sep; ():1-11. PubMed ID: 37713363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A computational quest for identifying potential vaccine candidates against
    Ullah A; Ul Haq M; Iqbal M; Irfan M; Khan S; Muhammad R; Ullah A; Khurram M; Alharbi M; Alasmari AF; Ahmad S
    J Biomol Struct Dyn; 2024 Apr; 42(6):2976-2989. PubMed ID: 37177816
    [No Abstract]   [Full Text] [Related]  

  • 6. Unveiling MurE ligase potential inhibitors for treating multi-drug resistant
    Altharawi A; Alqahatani SM; Alanazi MM; Tahir Ul Qamar M
    J Biomol Struct Dyn; 2024 Mar; 42(5):2358-2368. PubMed ID: 37099644
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening of potential phytomolecules against MurG as drug target in nosocomial pathogen
    Lokhande KB; Pawar SV; Madkaiker S; Shrivastava A; Venkateswara SK; Nawani N; Wani M; Ghosh P; Singh A
    J Biomol Struct Dyn; 2024; 42(1):495-508. PubMed ID: 36974974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Determination of Potential Multiprotein Targeting Natural Compounds for Rational Drug Design Against SARS-COV-2.
    Muhseen ZT; Hameed AR; Al-Hasani HMH; Ahmad S; Li G
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33525411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Novel Anti-Cancer Agents by Targeting OGG1 Enzyme Using Integrated Bioinformatics Methods.
    Muhseen ZT; Ali MH; Jaber NR; Mashrea DS; Alfalki AM; Li G
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome-Wide Screening of Potential Vaccine Targets against
    Malik M; Khan S; Ullah A; Hassan M; Haq MU; Ahmad S; Al-Harbi AI; Sanami S; Abideen SA; Irfan M; Khurram M
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymuconolactone decarboxylase is a prospective molecular target for multi-drug resistant Acinetobacter baumannii-computational modeling, molecular docking and dynamic simulation studies.
    Rana S; Skariyachan S; Uttarkar A; Niranjan V
    Comput Biol Med; 2023 May; 157():106793. PubMed ID: 36944292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure based virtual screening and molecular dynamics of natural anti-biofilm compounds against SagS response regulator/sensor kinase in
    Behera SK; Panda AK; Mishra R; Mahanty A; Bisht SS
    J Biomol Struct Dyn; 2023; 41(13):6011-6026. PubMed ID: 35869653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel chemical scaffolds against kinase domain of cancer causing human epidermal growth factor receptor 2: a systemic chemoinformatic approach.
    Alrumaihi F
    J Biomol Struct Dyn; 2023 Jul; ():1-11. PubMed ID: 37424103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study.
    Alabbas AB
    Saudi Pharm J; 2023 Sep; 31(9):101745. PubMed ID: 37638221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analysis of marine algal compounds for obesity management against pancreatic lipase.
    Prabhakar L; Dicky John DG; Singh SR; Murali A
    J Biomol Struct Dyn; 2023 Jul; 41(11):4863-4872. PubMed ID: 35575483
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Joshi T; Joshi T; Sharma P; Pundir H; Chandra S
    J Biomol Struct Dyn; 2021 Aug; 39(13):4816-4834. PubMed ID: 32568603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer.
    Khan A; Waheed Y; Kuttikrishnan S; Prabhu KS; El-Elimat T; Uddin S; Alali FQ; Agouni A
    Front Pharmacol; 2024; 15():1352907. PubMed ID: 38434705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of iridoids and their similar structures as antineoplastic drugs by
    Neupane P; Adhikari Subin J; Adhikari R
    J Biomol Struct Dyn; 2024 Feb; ():1-16. PubMed ID: 38345021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.